Low Level Light Therapy

What is Low-Level Laser Therapy (LLLT)?

Low-Level Laser Therapy (LLLT), also referred to as photobiomodulation therapy, is an FDA-approved, non-invasive treatment designed to address meibomian gland dysfunction (MGD) and evaporative dry eye disease.

Dr. Jason Besecker is proud to be among the first providers in Idaho to offer this advanced, evidence-based therapy for patients suffering from chronic dry eye. LLLT utilizes specific wavelengths of low-intensity red and near-infrared light to penetrate the eyelid tissues and stimulate cellular activity within the meibomian glands. The absorbed light energy enhances mitochondrial function, improving cellular metabolism, reducing inflammation, and promoting natural tissue repair.

Unlike traditional surgical or ablative lasers, LLLT does not cut or burn tissue. Instead, it works at the cellular level to normalize gland function and improve the quality of the tear film. By targeting the underlying inflammation and obstruction that cause gland dysfunction, LLLT provides long-term improvement in ocular comfort, tear stability, and overall eye health.
​​​​​​​

LLLT Procedure for Dry Eye

Each session lasts about 15 minutes and is performed in-office, 2-3x a week as needed.

Side Effects of LLLT for Dry Eye

LLLT is considered a safe and well-tolerated procedure with minimal risk. Adverse effects, when they occur, are generally mild and transient. Possible side effects may include:

• Mild erythema (redness) of the eyelids

• Sensation of warmth or tingling in the treated area

• Temporary light sensitivity

These symptoms typically resolve within a few hours of treatment.

Contraindications of LLLT for Dry Eye

(Non-inclusive list)

• Pregnancy or nursing

• Active ocular or periocular infection

• Recent ocular surgery or trauma

• Photosensitivity or use of photosensitizing medications (e.g., Accutane, doxycycline)

• Known malignancy or suspicious skin lesions near the treatment area

• Epilepsy with photosensitivity

LLLT for Dry Eye

Aftercare

• Avoid direct sunlight for 48 hours post-treatment.

• Apply a broad-spectrum sunscreen (SPF 30 or higher) daily to treated areas.

• Avoid tanning beds and UV light exposure for at least 2 weeks.

• Refrain from using makeup or topical products on the eyelids until any redness has resolved.

• Avoid hot showers, saunas, and steam exposure for 24–48 hours.

• Follow any additional aftercare or lubrication recommendations provided by your eye care professional.
  ​​​​​​​
  

​​​​​​​Candidates for LLLT Treatment

LLLT is an excellent therapeutic option for patients who have:

• Meibomian gland dysfunction (MGD)

• Ocular rosacea or chronic eyelid inflammation

• Evaporative dry eye symptoms unresponsive to artificial tears

• Limited improvement with prescription dry eye medications such as Xiidra, Restasis, or Cequa

• Preference for a non-invasive, drug-free, and clinically validated treatment approach